{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:42:53Z","timestamp":1777869773816,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572512"],"award-info":[{"award-number":["81572512"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["201803025"],"award-info":[{"award-number":["201803025"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.prp.2020.153286","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T12:57:35Z","timestamp":1604926655000},"page":"153286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["ALK rearrangement in TFE3-positive renal cell carcinoma: Alternative diagnostic option to exclude Xp11.2 translocation carcinoma"],"prefix":"10.1016","volume":"216","author":[{"given":"Yiqi","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongqian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weidong","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5151","key":"10.1016\/j.prp.2020.153286_bib0005","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.8122112","article-title":"Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin\u2019s lymphoma","volume":"263","author":"Morris","year":"1994","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.prp.2020.153286_bib0010","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1158\/2159-8290.CD-12-0009","article-title":"A cancer subtype with a shared target","volume":"2","author":"Mano","year":"2012","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.prp.2020.153286_bib0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc2291","article-title":"The anaplastic lymphoma kinase in the pathogenesis of cancer","volume":"8","author":"Chiarle","year":"2008","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2020.153286_bib0020","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood.V89.4.1394","article-title":"Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1","volume":"89","author":"Pulford","year":"1997","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.prp.2020.153286_bib0025","doi-asserted-by":"crossref","first-page":"594","DOI":"10.2174\/187152007784111340","article-title":"Oncogenic fusion tyrosine kinases as molecular targets for anti-cancer therapy","volume":"7","author":"Gunby","year":"2007","journal-title":"Anticancer Agents Med. Chem."},{"issue":"7153","key":"10.1016\/j.prp.2020.153286_bib0030","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature05945","article-title":"Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer","volume":"448","author":"Soda","year":"2007","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.prp.2020.153286_bib0035","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0002-9440(10)64550-6","article-title":"TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors","volume":"157","author":"Lawrence","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"10","key":"10.1016\/j.prp.2020.153286_bib0040","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrc3580","article-title":"Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology","volume":"13","author":"Hallberg","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.prp.2020.153286_bib0045","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1158\/1541-7786.MCR-08-0522","article-title":"Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers","volume":"7","author":"Lin","year":"2009","journal-title":"Mol. Cancer Res."},{"issue":"3","key":"10.1016\/j.prp.2020.153286_bib0050","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/modpathol.2010.213","article-title":"Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum","volume":"24","author":"Debelenko","year":"2011","journal-title":"Mod. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2020.153286_bib0055","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/gcc.20839","article-title":"ALK rearrangement in sickle cell trait-associated renal medullary carcinoma","volume":"50","author":"Marino-Enriquez","year":"2011","journal-title":"Genes Chromosomes cancer"},{"issue":"18","key":"10.1016\/j.prp.2020.153286_bib0060","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1002\/cncr.27391","article-title":"Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method","volume":"118","author":"Sugawara","year":"2012","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.prp.2020.153286_bib0065","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/modpathol.2012.107","article-title":"ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients","volume":"25","author":"Sukov","year":"2012","journal-title":"Mod. Pathol."},{"issue":"5","key":"10.1016\/j.prp.2020.153286_bib0070","doi-asserted-by":"crossref","first-page":"452","DOI":"10.4132\/KoreanJPathol.2013.47.5.452","article-title":"ALK-positive renal cell carcinoma in a large series of consecutively resected korean renal cell carcinoma patients","volume":"47","author":"Lee","year":"2013","journal-title":"Korean J. Pathol."},{"issue":"2","key":"10.1016\/j.prp.2020.153286_bib0075","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00428-013-1520-3","article-title":"Increased ALK1 copy number and renal cell carcinoma-a case report","volume":"464","author":"Ryan","year":"2014","journal-title":"Virchows Arch."},{"issue":"6","key":"10.1016\/j.prp.2020.153286_bib0080","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/PAS.0000000000000179","article-title":"VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy?","volume":"38","author":"Smith","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"issue":"10","key":"10.1016\/j.prp.2020.153286_bib0085","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/gcc.22382","article-title":"Expanding the spectrum of ALK-rearranged renal cell carcinomas in children: identification of a novel HOOK1-ALK fusion transcript","volume":"55","author":"Cajaiba","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"10.1016\/j.prp.2020.153286_bib0090","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/gcc.22346","article-title":"ALK-rearranged renal cell carcinomas in children","volume":"55","author":"Cajaiba","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"issue":"11","key":"10.1016\/j.prp.2020.153286_bib0095","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.prp.2016.07.015","article-title":"ALK rearrangements-associated renal cell carcinoma (RCC) with unique pathological features in an adult","volume":"212","author":"Jeanneau","year":"2016","journal-title":"Pathol. Res. Pract."},{"issue":"6","key":"10.1016\/j.prp.2020.153286_bib0100","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/PAS.0000000000000610","article-title":"Two cases of renal cell carcinoma harboring a novel STRN-ALK fusion gene","volume":"40","author":"Kusano","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"issue":"10","key":"10.1016\/j.prp.2020.153286_bib0105","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.prp.2016.07.004","article-title":"TFE3-positive renal cell carcinomas are not always Xp11 translocation carcinomas: report of a case with a TPM3-ALK translocation","volume":"212","author":"Thorner","year":"2016","journal-title":"Pathol. Res. Pract."},{"issue":"1","key":"10.1016\/j.prp.2020.153286_bib0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/his.13185","article-title":"Genetic analysis and clinicopathological features of ALK-rearranged renal cell carcinoma in a large series of resected Chinese renal cell carcinoma patients and literature review","volume":"71","author":"Yu","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2020.153286_bib0115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cancergen.2017.11.010","article-title":"ALK-TPM3 rearrangement in adult renal cell carcinoma: report of a new case showing loss of chromosome 3 and literature review","volume":"221","author":"Bodokh","year":"2018","journal-title":"Cancer Genet."},{"issue":"12","key":"10.1016\/j.prp.2020.153286_bib0120","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/pin.12592","article-title":"A case of anaplastic lymphoma kinase-positive renal cell carcinoma coincident with Hodgkin lymphoma","volume":"67","author":"Oyama","year":"2017","journal-title":"Pathol. Int."},{"key":"10.1016\/j.prp.2020.153286_bib0125","doi-asserted-by":"crossref","DOI":"10.1007\/s00428-020-02752-5","article-title":"ALK-rearranged renal cell carcinoma with a novel PLEKHA7-ALK translocation and metanephric adenoma-like morphology","author":"Hang","year":"2020","journal-title":"Virchows Arch."},{"issue":"3","key":"10.1016\/j.prp.2020.153286_bib0130","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3349\/ymj.2020.61.3.262","article-title":"Characteristics of renal cell carcinoma harboring TPM3-ALK fusion","volume":"61","author":"Woo","year":"2020","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.prp.2020.153286_bib0135","series-title":"ALK Fusions in Renal Cell Carcinoma: Response to Entrectinib","author":"Tao","year":"2018"},{"issue":"11","key":"10.1016\/j.prp.2020.153286_bib0140","doi-asserted-by":"crossref","first-page":"152651","DOI":"10.1016\/j.prp.2019.152651","article-title":"Targeted next-generation sequencing revealed distinct clinicopathologic and molecular features of VCL-ALK RCC: a unique case from an older patient without clinical evidence of sickle cell trait","volume":"215","author":"Wang","year":"2019","journal-title":"Pathol. Res. Pract."},{"issue":"1","key":"10.1016\/j.prp.2020.153286_bib0145","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.eururo.2018.03.032","article-title":"Responses to Alectinib in ALK-rearranged papillary renal cell carcinoma","volume":"74","author":"Pal","year":"2018","journal-title":"Eur. Urol."},{"issue":"2","key":"10.1016\/j.prp.2020.153286_bib0150","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5114\/pjp.2018.76693","article-title":"A review of ALK-rearranged renal cell carcinomas with a focus on clinical and pathobiological aspects","volume":"69","author":"Kuroda","year":"2018","journal-title":"Pol. J. Pathol."},{"issue":"16","key":"10.1016\/j.prp.2020.153286_bib0155","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1002\/cncr.31578","article-title":"The classification of pediatric and young adult renal cell carcinomas registered on the children\u2019s oncology group (COG) protocol AREN03B2 after focused genetic testing","volume":"124","author":"Cajaiba","year":"2018","journal-title":"Cancer"},{"issue":"18","key":"10.1016\/j.prp.2020.153286_bib0160","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1006448","article-title":"Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer","volume":"363","author":"Kwak","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.prp.2020.153286_bib0165","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1016\/j.jtho.2017.06.002","article-title":"Cases of ALK-Rearranged lung cancer with 5-Year progression-free survival with crizotinib as initial precision therapy","volume":"12","author":"Rangachari","year":"2017","journal-title":"J. Thorac. Oncol."},{"issue":"14","key":"10.1016\/j.prp.2020.153286_bib0170","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1002\/cncr.29368","article-title":"Characterization of adolescent and pediatric renal cell carcinoma: a report from the children\u2019s oncology group study aren03b2","volume":"121","author":"Geller","year":"2015","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.prp.2020.153286_bib0175","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.tcb.2006.07.004","article-title":"The structure and regulation of vinculin","volume":"16","author":"Ziegler","year":"2006","journal-title":"Trends Cell Biol."},{"issue":"3","key":"10.1016\/j.prp.2020.153286_bib0180","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.bbrc.2015.01.014","article-title":"Oncogenic TPM3-ALK activation requires dimerization through the coiled-coil structure of TPM3","volume":"457","author":"Amano","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.prp.2020.153286_bib0185","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ejca.2006.12.005","article-title":"TPM3-ALK expression induces changes in cytoskeleton organisation and confers higher metastatic capacities than other ALK fusion proteins","volume":"43","author":"Armstrong","year":"2007","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.prp.2020.153286_bib0190","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/modpathol.2011.169","article-title":"Molecular heterogeneity of TFE3 activation in renal cell carcinomas","volume":"25","author":"Macher-Goeppinger","year":"2012","journal-title":"Mod. Pathol."},{"issue":"10","key":"10.1016\/j.prp.2020.153286_bib0195","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/PAS.0b013e3181f17ac0","article-title":"Distinctive subset of PEComas harbor TFE3 gene fusions","volume":"34","author":"Argani","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"issue":"10","key":"10.1016\/j.prp.2020.153286_bib0200","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.5858\/arpa.2015-0196-RA","article-title":"MiT family translocation-associated renal cell carcinoma: a contemporary update with emphasis on morphologic, immunophenotypic, and molecular mimics","volume":"139","author":"Magers","year":"2015","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"2","key":"10.1016\/j.prp.2020.153286_bib0205","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.cll.2005.01.008","article-title":"Translocation carcinomas of the kidney","volume":"25","author":"Argani","year":"2005","journal-title":"Clin. Lab. Med."},{"issue":"5","key":"10.1016\/j.prp.2020.153286_bib0210","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/PAS.0000000000000835","article-title":"RBM10-TFE3 renal cell carcinoma: a potential diagnostic pitfall due to cryptic intrachromosomal Xp11.2 inversion resulting in false-negative TFE3 FISH","volume":"41","author":"Argani","year":"2017","journal-title":"Am. J. Surg. Pathol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033820321415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033820321415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:38:23Z","timestamp":1777559903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033820321415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0344033820321415"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2020.153286","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ALK rearrangement in TFE3-positive renal cell carcinoma: Alternative diagnostic option to exclude Xp11.2 translocation carcinoma","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2020.153286","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"153286"}}